Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia
The Journal of Infectious Diseases · 01.02.2023 · 227 (3) · 311-316
DOI: 10.1093/infdis/jiac368 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 09.09.2022. Verfasst von Jennifer M Dan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA. Hauptthemen laut MEDLINE: Bacteriophages, Phage Therapy, Pneumonia, Pseudomonas Infections. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Bacteriophage therapy is the use of viruses to kill bacteria for the treatment of antibiotic-resistant infections. Little is known about the human immune response following phage therapy. We report the development of phage-specific CD4+ T cells alongside rising phage-specific immunoglobulin G and neutralizing antibodies in response to adjunctive bacteriophage therapy used to treat a multidrug-resistant Pseudomonas aeruginosa pneumonia in a lung transplant recipient. Clinically, treatment was considered a success despite the development phage-specific immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.
- Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA.
- AmpliPhi Biosciences, San Diego, California, USA.
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Diego, La Jolla, California, USA.
- Department of Surgery. Division of Cardiovascular and Thoracic Surgery, University of California, San Diego, La Jolla, California, USA.
- AmpliPhi Australia, Sydney, Australia.
ORCID-Profile: Jennifer M Dan
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Dan, J. M., Lehman, S. M., Al-Kolla, R., Penziner, S., Afshar, K., Yung, G., Golts, E., Law, N., Logan, C., Kovach, Z., Mearns, G., Schooley, R. T., Aslam, S., & Crotty, S. (2023). Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia. The Journal of Infectious Diseases, 227(3), 311-316. https://doi.org/10.1093/infdis/jiac368
Vancouver
Dan JM, Lehman SM, Al-Kolla R, Penziner S, Afshar K, Yung G, et al. Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia. The Journal of Infectious Diseases. 2023;227(3):311-316. doi:10.1093/infdis/jiac368
BibTeX
@article{Dan2023,
author = {Dan, Jennifer M and Lehman, Susan M and Al-Kolla, Rita and Penziner, Samuel and Afshar, Kamyar and Yung, Gordon and Golts, Eugene and Law, Nancy and Logan, Cathy and Kovach, Zsuzsanna and Mearns, Gill and Schooley, Robert T and Aslam, Saima and Crotty, Shane},
title = {Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {227},
number = {3},
pages = {311--316},
doi = {10.1093/infdis/jiac368}
}
EUVIMED